Antonelli Alessandro, Delle Sedie Andrea, Fallahi Poupak, Ferrari Silvia Martina, Maccheroni Marco, Ferrannini Ele, Bombardieri Stefano, Riente Lucrezia
From the Department of Internal Medicine and the Rheumatology Unit, University of Pisa, and the Endocrinological Laboratory, Azienda Ospedaliera Pisana, Pisa, Italy.
J Rheumatol. 2006 Oct;33(10):2026-8.
To evaluate the prevalence of thyroid disorders in a group of patients with psoriatic arthritis (PsA).
A complete thyroid investigation was carried out in 80 patients with PsA, in gender- and age-matched subjects (1:5) drawn from the general population (controls), and in 112 patients with rheumatoid arthrtitis (RA) with similar iodine intake.
Anti-thyroid peroxidase antibodies (AbTPO), a hypoechoic thyroid, and subclinical hypothyroidism were significantly more frequent in women with PsA than in control women, and their frequency was similar to that in patients with RA (positive AbTPO titer 28%, 12%, and 31%; hypoechoic thyroid 31%, 16%, and 36%; subclinical hypothyroidism 25%, 8%, and 12%, respectively). Among men, positive AbTPO titers and a hypoechoic thyroid were found more frequently in the patients with PsA and RA than in controls (positive AbTPO titer 14%, 5%, and 2%; hypoechoic thyroid 16%, 10%, and 3%, respectively). All patients with PsA with subclinical hypothyroidism had polyarticular involvement (p </= 0.05) and a longer disease duration (years 19 +/- 15 vs 11 +/- 8, p = 0.03) than patients with euthyroid PsA. The prevalence of subclinical hyperthyroidism, thyroid nodules, and thyroid enlargement was not significantly different among the 3 groups.
Our results demonstrate a significantly higher prevalence of thyroid autoimmunity (positive AbTPO, hyoechoic thyroid) findings in men and women with PsA and of subclinical hypothyroidism in women with PsA than in the general population. Therefore, thyroid function tests, an AbTPO assay, and thyroid ultrasound should be performed as part of the clinical evaluation, particularly in women with PsA.
评估一组银屑病关节炎(PsA)患者中甲状腺疾病的患病率。
对80例PsA患者、从普通人群中选取的性别和年龄匹配的受试者(1:5)(对照组)以及112例碘摄入量相似的类风湿关节炎(RA)患者进行了全面的甲状腺检查。
PsA女性患者中抗甲状腺过氧化物酶抗体(AbTPO)、甲状腺低回声以及亚临床甲状腺功能减退的发生率显著高于对照女性,且其发生率与RA患者相似(AbTPO阳性滴度分别为28%、12%和31%;甲状腺低回声分别为31%、16%和36%;亚临床甲状腺功能减退分别为25%、8%和12%)。在男性中,PsA和RA患者中AbTPO阳性滴度和甲状腺低回声的发生率高于对照组(AbTPO阳性滴度分别为14%、5%和2%;甲状腺低回声分别为16%、10%和3%)。与甲状腺功能正常的PsA患者相比,所有亚临床甲状腺功能减退的PsA患者均有多关节受累(p≤0.05)且病程更长(19±15年 vs 11±8年,p = 0.03)。三组中亚临床甲状腺功能亢进、甲状腺结节和甲状腺肿大的患病率无显著差异。
我们的结果表明,与普通人群相比,PsA男性和女性中甲状腺自身免疫(AbTPO阳性、甲状腺低回声)的发生率显著更高,且PsA女性中亚临床甲状腺功能减退的发生率更高。因此,应将甲状腺功能检查、AbTPO检测和甲状腺超声检查作为临床评估的一部分,尤其是对PsA女性患者。